PLEOMORPHIC RHABDOMYOSARCOMA

Clinical trials for PLEOMORPHIC RHABDOMYOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new PLEOMORPHIC RHABDOMYOSARCOMA trials appear

Sign up with your email to follow new studies for PLEOMORPHIC RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New Two-Pronged attack tested against rare cancers before surgery

Disease control Ongoing

This early-stage study is testing the safety of combining two immunotherapy drugs, nivolumab and BO-112, given before surgery for patients with operable soft tissue sarcoma. The goal is to see if stimulating the immune system to attack the tumor before it is removed can improve o…

Matched conditions: PLEOMORPHIC RHABDOMYOSARCOMA

Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

PLEOMORPHIC RHABDOMYOSARCOMA

Get alerted when new PLEOMORPHIC RHABDOMYOSARCOMA trials appear

New Two-Pronged attack tested against rare cancers before surgery